Work

Results of a phase 1, dose-finding study of Debio 0123 as monotherapy in adult patients with advanced solid tumors: Safety, pharmacokinetic, and preliminary antitumor activity data.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.3120

Authors: Kyriakos P. Papadopoulos, Manish Sharma, Reinhard Dummer, Ilaria Colombo, Egle Ramelyte, Leigh Seamon, Drew W. Rasco, Victor Rodriguez Freixinos, Vito Dozio, Tri Tat, Noemie Luong, Aliaksandr Hurynovich, Mokhtar Omar, Sandrine Micallef, Anne Bellon, Esteban Rodrigo Imedio, Anastasios Stathis

Institutions: South Texas Accelerated Research Therapeutics, University Hospital Zurich, Istituto Oncologico della Svizzera Italiana, Debiopharm (Switzerland)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Debiopharm

OpenAlex ID: W4399667145

Cites:

Cited by: 10

Related to: 10